Myriad Pharmaceuticals, Inc.
Management Performance—Incentive Bonus Program
Fiscal Year 2010
The Compensation Committee of the Board of Directors of Myriad Pharmaceuticals, Inc. has implemented an annual
management performance—incentive bonus program for the purpose of establishing annual performance objectives for our
executives, including our named executive officers, to align their performance with the overall goals and objectives for Myriad.
This process will commence in the fourth quarter of each fiscal year with each executive meeting with our President and CEO to
discuss management business objectives (collectively “MBOs”) for the ensuing fiscal year. After review and discussion, our
President and CEO will present the executive officers’ MBOs to the Compensation Committee for final approval. Similarly, our
President and CEO meets with the Compensation Committee at the end of each fiscal year to propose his MBOs for the ensuing
fiscal year which, after review and discussion, are finalized by the Compensation Committee.
After the end of each fiscal year, annual bonus awards will then be determined by the Compensation Committee for each
executive officer based on i) a target bonus award opportunity, ii) the company’s overall financial performance and financial
condition, and iii) the individual executive officer’s performance against the MBOs established for such executive officer, the
company’s financial performance in the areas of responsibility of the executive officer and other significant accomplishments
and contributions of the executive officer.
For fiscal year 2010, the Compensation Committee established the following target bonus award opportunities for each
executive officer, based on a percentage of base salary:
The actual bonus award will be determined by the Compensation Committee by multiplying the target bonus percentage for all
executive officers by a factor of 0 to 1.2 based upon the Compensation Committee’s assessment of the Company’s overall